Why a DCF Doesn't Fit Welltower Inc. (WELL)
REIT - Healthcare Facilities · NYSE
A cash-flow DCF is not the right model for WELL
Welltower Inc. is a bank, insurer, or real estate company. A standard discounted cash flow model values a business on its free cash flow, but for these companies free cash flow is not a clean measure of value. Banks and insurers are valued on book value, return on equity, and a price-to-earnings multiple; REITs are valued on funds from operations (FFO) and dividends, not free cash flow. Running a free cash flow DCF here would produce a misleading number, so none is shown.
Current Price
$241.08
COMPETITIVE MOAT
↑Scale and Diversified Portfolio
Welltower's extensive portfolio of healthcare facilities across various segments provides significant operational scale. This diversification across senior housing, post-acute care, and outpatient medical properties mitigates risks associated with any single segment.
↑Long-Term Leases and Tenant Relationships
The company benefits from long-term lease agreements with established healthcare operators. These contracts create predictable revenue streams and foster strong, sticky relationships with key tenants.
↑Demographic Tailwinds
Aging demographics and increasing demand for senior housing and healthcare services provide a secular tailwind. This sustained demand supports occupancy and rental growth for Welltower's properties.
INVESTMENT RISKS
↓Regulatory and Reimbursement Changes
Changes in healthcare regulations or government reimbursement policies could negatively affect the profitability of Welltower's tenants. This could lead to increased tenant defaults or reduced rental payments.
↓Competition for Acquisitions
The attractive nature of healthcare real estate may lead to increased competition for high-quality acquisition opportunities. This could drive up acquisition costs and limit Welltower's growth potential.
↓Property Obsolescence and Capital Expenditures
Healthcare facilities require ongoing maintenance and modernization. Failure to invest in property upgrades could lead to obsolescence and decreased tenant demand, requiring significant capital expenditures.
Company Overview
Welltower Inc. (NYSE:WELL), an S&P 500 company based in Toledo, Ohio, is a leader in reshaping healthcare infrastructure. This Real Estate Investment Trust (REIT) strategically collaborates with premier operators in seniors housing, post-acute care, and health systems. Their core mission is to finance the vital property assets required to expand innovative care delivery models, thereby enhancing overall public wellness and healthcare experiences. Welltower's portfolio encompasses a variety of properties, including seniors housing, post-acute communities, and outpatient medical facilities, all situated primarily within key, rapidly growing markets across the United States, Canada, and the United Kingdom.
Frequently Asked Questions
Why isn't a discounted cash flow model right for valuing Welltower Inc.?
As a REIT, Welltower Inc. must pay out most of its income as dividends and carries heavy non-cash depreciation on its buildings, so reported net income and free cash flow understate how much the properties actually earn. A DCF built on those figures misses the real cash the portfolio produces. A REIT is read on funds from operations and dividends instead.
How is Welltower Inc. (WELL) valued instead?
Welltower Inc. is better read through price-to-FFO, which uses funds from operations, and the dividend yield rather than price-to-earnings, together with occupancy and the quality of its properties. The WELL PE view is a starting point, but multiples based on funds from operations fit a REIT better.
Learn More
- See WELL PE Valuation → — The earnings-based method that fits this kind of business
- PE Methodology — Guide to PE ratio stock valuation
- P/E Ratio — How an earnings multiple values a stock
- Price-to-Book — A core metric for valuing banks and insurers
- Return on Equity — Why ROE drives bank and insurer valuations
Related Valuations
All Real Estate valuationsDCF and P/E value WELL with different methods and assumptions, so the two conclusions can differ. Compare the P/E fair value.
Price as of 2026-07-29. Financial data from Financial Modeling Prep (trailing twelve months) · Valuation methodology by Charlie Wang.
This is an estimate, not investment advice.